Partners – Page 3

These consensus guidelines are significant not only for their key updates to clinical practice but for their representation of a more [...]

0

Congratulations to Dr. Robert Lisak: recipient of ANA’s Distinguished Neurology Teacher Award

MS Community, Partners

The CMSC Board, staff, and members would like to congratulate Dr. Robert Lisak for his selection as a recipient of the 2021 Distinguished [...]

0

Study on cognitive processing speed changes in RMS subjects treated with Ozanimod

INforMS, Partners

Bristol Myers Squibb is conducting a Phase 3b Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing [...]

0

New data for Ocrevus disease progression (ocrelizumab) reinforce significant slowing

INforMS, Partners

– 85% of treatment-naïve, early-stage relapsing-remitting multiple sclerosis (RRMS) patients achieved no evidence of disease activity [...]

0

New Genentech data at 2021 AAN highlight impact & breadth of neuroscience portfolio

INforMS, Partners

Evrysdi (risdiplam) 2-year FIREFISH Part 2 data show improvement in motor function in infants with Type 1 spinal muscular atrophy [...]

0

Janssen announces U.S. FDA approval of PONVORY™ (ponesimod)

INforMS, Partners

Head-to-head pivotal clinical trial results showed PONVORY™ treatment led to nearly a third fewer annual relapses than [...]

0

NeurologyLive® & the CMSC launches MS Cure Connections® Video Series

CMSC PR, Partners

A diverse panel including an expert neurologist, a psychologist, a patient, and a care partner discuss the patient's journey with [...]

0

FDA approval of intramuscular Plegridy (Peginterferon beta-1a)

INforMS, Partners

Please be advised of the recent approval by the FDA for intramuscular Plegridy (Peginterferon beta-1a) and an update to other sections [...]

0

Genentech’s enspryng for Neuromyelitis Optica Spectrum Disorder

INforMS, Partners

First and only FDA-approved subcutaneous treatment option for anti-aquaporin-4 antibody positive NMOSD that can be self-administered by a [...]

0

Mylan brings critical access to the multiple sclerosis community

INforMS, MS Community, Partners

HERTFORDSHIRE, England, and PITTSBURGH– August 19, 2020 – Mylan N.V. (NASDAQ: MYL) today announced the launch of the first [...]

Elizabeth Porco

11

0

Category Archives: "Partners"

Recent Posts

Contact Us